Eysz is a neurotechnology company developing software that uses eye-tracking to objectively assess brain function following neurological injury. The company focuses on rapid, non-invasive detection of concussion-related impairments that are often missed by subjective symptom-based evaluations.

Its platform analyzes subtle eye movement patterns during short visual tasks to extract biomarkers linked to oculomotor control and neural integrity. These measurements are processed through proprietary algorithms to generate standardized outputs that can support clinical decision-making and longitudinal monitoring.

Eysz’s technology is intended for use in clinical, sports, and rehabilitation settings, particularly for concussion screening, return-to-play decisions, and brain injury monitoring. The company positions its software as a diagnostic support and measurement tool rather than a therapeutic or imaging device.